Literature DB >> 17509490

Acute treatment and long-term management of stroke in developing countries.

Michael Brainin1, Yvonne Teuschl, Lalit Kalra.   

Abstract

Developing countries have some of the highest stroke mortality rates in the world that account for over two-thirds of stroke deaths worldwide. Hospital-based studies suggest that the patterns of stroke types and causes of stroke differ between developing and developed countries, resulting in differing needs for acute and long-term care. Data on stroke care provision in developing countries are sparse and most of the available studies are biased towards urban settings in reasonably resourced health-care systems. A general overview shows that the quality and quantity of stroke care is largely patchy in low-income and middle-income countries, with areas of excellence intermixed with areas of severe need, depending upon patients' location, socioeconomic status, education, and cultural beliefs. Here we review the available literature on acute and long-term stroke management in developing countries. On the basis of available studies, largely from developed countries, we discuss the need to develop basic organised stroke-unit care in developing countries.

Entities:  

Mesh:

Year:  2007        PMID: 17509490     DOI: 10.1016/S1474-4422(07)70005-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  50 in total

1.  Neuroprotective effect of recombinant adeno-associated virus human thioredoxin-PR39 on acute cerebral infarction in rats.

Authors:  Yu-Dong Guo; Teng Huang; Wen-Hua Sheng; Yun-Fei Guan; Yi-Feng Du; You-Ting Lin; Xi-Yun Ruan
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

2.  Delayed hyperbaric oxygen therapy promotes neurogenesis through reactive oxygen species/hypoxia-inducible factor-1α/β-catenin pathway in middle cerebral artery occlusion rats.

Authors:  Qin Hu; Xiping Liang; Di Chen; Yujie Chen; Desislava Doycheva; Junjia Tang; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

3.  Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings.

Authors:  Aaron L Berkowitz; M Brandon Westover; Matt T Bianchi; Sherry H-Y Chou
Journal:  Neurology       Date:  2014-08-13       Impact factor: 9.910

4.  PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE.

Authors:  Michael R Debaun; Najibah A Galadanci; Adetola A Kassim; Lori C Jordan; Sharon Phillips; Muktar H Aliyu
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 5.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

6.  Tumour necrosis factor alpha, ınterleukin 10 and ınterleukin 6 gene polymorphisms of ıschemic stroke patients ın south Marmara region of Turkey.

Authors:  Adile Ozkan; Fatma Sılan; Ahmet Uludağ; Yıldız Degirmenci; Handan Isin Ozisik Karaman
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats.

Authors:  Xiping Liang; Qin Hu; Bo Li; Devin McBride; Hetao Bian; Pierre Spagnoli; Di Chen; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2014-08-19       Impact factor: 7.914

Review 8.  Management of NCD in low- and middle-income countries.

Authors:  William Checkley; Hassen Ghannem; Vilma Irazola; Sylvester Kimaiyo; Naomi S Levitt; J Jaime Miranda; Louis Niessen; Dorairaj Prabhakaran; Cristina Rabadán-Diehl; Manuel Ramirez-Zea; Adolfo Rubinstein; Alben Sigamani; Richard Smith; Nikhil Tandon; Yangfeng Wu; Denis Xavier; Lijing L Yan
Journal:  Glob Heart       Date:  2014-12

9.  Aspirin for acute stroke of unknown etiology in resource-limited settings: a decision analysis.

Authors:  Aaron L Berkowitz; M Brandon Westover; Matt T Bianchi; Sherry H-Y Chou
Journal:  Neurology       Date:  2014-07-23       Impact factor: 9.910

10.  Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO in rats.

Authors:  Guangyong Wu; Devin W McBride; John H Zhang
Journal:  Neurobiol Dis       Date:  2017-11-28       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.